{"id":"074047fc-3e73-4564-a61d-9253cbb45d5c","slug":"fda-k233655-abbott-lingo","filingNumber":"K233655","filingType":"fda_510k","jurisdiction":"us_fda","applicantCompanyId":"9c75b380-8657-4f59-ba05-55e438eea7a9","filingDate":"2023-11-14T12:00:00.000Z","decisionDate":"2024-05-29T12:00:00.000Z","status":"cleared","clearanceScope":"510(k) clearance for the Abbott Lingo OTC continuous glucose monitoring system; cleared 2024.","sources":[{"url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K233655","title":"FDA 510(k) K233655 - Abbott Lingo OTC CGM","sourceName":"FDA 510(k) Database (primary)"}],"verificationPosture":"verified","capFlagNotes":null,"relatedIncidentId":null,"reviewStatus":"reviewed","deprecatedAt":null,"deprecationReason":null,"createdAt":"2026-06-04T23:09:22.605Z","updatedAt":"2026-06-05T15:35:47.498Z","applicantCompany":{"id":"9c75b380-8657-4f59-ba05-55e438eea7a9","slug":"abbott","name":"Abbott"},"modelLinks":[{"id":"20c5bd3c-912c-45df-946e-f7316655ec0b","modelId":"1c39a110-f475-4bbe-a687-83ca13024421","regulatoryFilingId":"074047fc-3e73-4564-a61d-9253cbb45d5c","createdAt":"2026-06-04T23:09:22.761Z","model":{"slug":"abbott-lingo","modelName":"Lingo"}}]}